DLF's Q1 FY27 pre-sales fall 94% YoY on zero launches, but management holds the FY27 target Realty
DLF booked just Rs 657 crore in Q1 FY27 pre-sales, down 94% YoY, entirely because no new projects launched in the quarter -- a timing gap, not a demand collapse, per management, which reiterated its Rs 20,000 crore FY27 pre-sales target and Rs 1 lakh crore five-year pipeline on planned Gurugram, Mumbai and Goa launches. Net profit still rose 4% YoY to Rs 793.9 crore on a Rs 15,200 crore net cash position. The miss is severe enough to note even though no guidance walk-back has occurred -- this is the detailed print behind the already-known 'soft Q1' story that has kept REALTY flat for three sessions running.
IHCL-Oriental Hotels merger stays on its original terms; new 20-year hotel management pacts signed as an interim step Hospitality & Tourism
No change has surfaced to the 25 IHCL-for-117 OHL share swap ratio or the H2 FY2028 completion target for IHCL's all-stock merger of Oriental Hotels. As an interim step, Oriental Hotels signed 20-year Hotel Management Agreements with IHCL effective Aug 1, 2026, replacing the older HOA structure -- consistent with, not a change to, the announced integration.
No successor named yet for TCS Chairman Chandrasekaran, with roughly six months left on the clock Information Technology
Three weeks after N. Chandrasekaran's Aug 13 announcement that he will not seek reappointment when his term ends Feb 2027, Tata Sons has not yet named a successor for the roughly Rs 16.24 lakh crore group. Whether this proves an orderly handover or the start of a disorderly transition compounding TCS's other governance overhangs (the Nashik POSH findings, senior attrition) remains an open question.
Maharashtra FDA temporarily suspends CEAT's methanol procurement licence over alleged Poisons Rules violations Automobiles
The Sept 1-15, 2026 suspension order cites alleged violations of Rules 9 and 11 of the Maharashtra Poisons Rules and 'competent person' licensing norms. CEAT says it has secured alternate methanol supply and expects no material impact on financials or operations; independent confirmation of that no-impact claim was not found. A real but narrow, short-duration regulatory flag on a BUY-rated stock.
India Glycols' three-way demerger becomes effective, leaving a materially smaller glycols-only entity under the ticker FMCG
The NCLT-approved split into India Glycols (glycols, Rs 345cr Q1 net revenue), IGL Spirits (spirits/biofuel, Rs 694cr) and Ennature Bio Pharma (biopharma, Rs 90cr) took effect Sept 1, 2026. MarketsMojo rates the remaining entity Hold, citing a below-average quality grade, modest 8.62% average ROCE and 2.60x Debt/EBITDA, even as recent quarters show improving profitability (H1 ROCE up to 11.79%, interest coverage up to 6.30x) -- evidence that leans toward, not against, the pending BUY-to-HOLD call review.